13F HOLDINGS REPORT
Pivotal bioVenture Partners Investment Advisor LLC
Quarter ended Q3 2025 · Filed November 13, 2025 · Accession 0001012975-25-000748
Total Value
$173.0M
Positions
10
Other Managers
1
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VAXCYTE INC | PCVX | 1,372,425 | $49.4M | 28.58% |
| 2 | OCULIS HOLDING AG | OCSAW | 2,300,774 | $40.4M | 23.38% |
| 3 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 2,120,508 | $40.0M | 23.11% |
| 4 | ZENAS BIOPHARMA INC | ZBIO | 779,045 | $17.3M | 10.00% |
| 5 | TREVI THERAPEUTICS INC | TRVI | 1,256,782 | $11.5M | 6.65% |
| 6 | IMMUNOME INC | IMNM | 502,512 | $5.9M | 3.40% |
| 7 | BIOAGE LABS INC | BIOA | 653,374 | $3.8M | 2.22% |
| 8 | RECURSION PHARMACEUTICALS IN | RXRX | 595,518 | $2.9M | 1.68% |
| 9 | RALLYBIO CORP | RLYB | 2,404,644 | $1.2M | 0.69% |
| 10 | BOLT BIOTHERAPEUTICS INC | BOLT | 94,573 | $503,128 | 0.29% |